Outcome of Board Meeting. INTIMATION OF APPOINTMENT OF STATUTORY AUDITOR. 1. Resignation of Statutory Auditor: The Board of Directors noted and accepted the resignation of M/s Sanjay ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories' Board accepted the resignation of its statutory auditor M/s Sanjay Rane & Associates LLP on July 31, 2025, effective from a resignation letter dated July 23, 2025. The outgoing auditor cited pre-occupation with other assignments as the reason for stepping down. The Audit Committee reviewed the resignation and confirmed that the auditor raised no concerns, issues, or qualifications regarding the company's financial statements or governance. To fill the casual vacancy, the Board recommended appointing M/s S S R V & Associates (FRN: 135901W), a peer-reviewed firm, effective July 29, 2025, pending shareholder approval at the next general meeting.
This is a routine auditor rotation with no governance red flags — the departing auditor did not flag any issues. The stock should not see material price movement from this announcement, though investors may note the mid-term nature of the change.